Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma

Inference and analysis of cell-cell communication using CellChat

Suoqin Jin, Christian F. Guerrero‐Juarez, Lihua Zhang et al. · Nature Communications · 2021 · 8.3K citations · Full text

Life Sciences, Bioinformatics, Cell Biology +17

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Juan W. Valle, Harpreet Wasan, Daniel H. Palmer et al. · New England Journal of Medicine · 2010 · 4.4K citations · Full text

Medicine, Oncology, Pharmacology +12

Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN

Zvi G. Fridlender, Jing Sun, Samuel Kim et al. · Cancer Cell · 2009 · 3.3K citations · Full text

Medicine, Immunology, Oncology +12

Bile acid metabolites control TH17 and Treg cell differentiation

Saiyu Hang, Donggi Paik, Lina Yao et al. · Nature · 2019 · 1.4K citations · Full text

Life Sciences, Biochemistry, Immunology +14

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 1K citations · Full text

Medicine, Oncology, Pharmacology +8